Meridian Bioscience
VIVO
#4549
Rank
$1.48 B
Marketcap
$33.97
Share price
0.00%
Change (1 day)
24.02%
Change (1 year)

P/E ratio for Meridian Bioscience (VIVO)

P/E ratio as of February 2024 (TTM): 35.0

According to Meridian Bioscience's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 35.0206. At the end of 2021 the company had a P/E ratio of 14.8.

P/E ratio history for Meridian Bioscience from 2001 to 2022

PE ratio at the end of each year

Year P/E ratio Change
202114.828.92%
202011.5-46.01%
201921.2-26.59%
201828.97.47%
201726.98%
201624.95.7%
201523.621.8%
201419.4-34.31%
201329.525.19%
201223.5

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
36.9 5.39%๐Ÿ‡บ๐Ÿ‡ธ USA
43.5 24.12%๐Ÿ‡บ๐Ÿ‡ธ USA
38.6 10.35%๐Ÿ‡บ๐Ÿ‡ธ USA
234 568.18%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.